Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled Corticosteroids and Exercise-Induced Inflammation in COPD
NCT02209974Phase 4Completed
- Sponsor
- Hospital Universitari Son Llàtzer
- Start
- Feb 2004
- Primary completion
- Nov 2009
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised trial in chronic obstructive pulmonary disease (COPD) comparing Inhaled Placebo with Inhaled corticosteroids (Fluticasone) (2 arms). Primary endpoint: Differences in response to exercise between healthy and COPD patients at 1 month. Started Feb 2004; status: completed.
02
Drugs
fluticasone propionate nasal spray
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT02209974.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02209974.